Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2003
10/02/2003US20030186424 Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors
10/02/2003US20030186423 Amidase from variovorax
10/02/2003US20030186422 Methods for the treatment of thrombosis
10/02/2003US20030186420 Prolidase and its gene and method for producing prolidase
10/02/2003US20030186418 Novel variant EGIII-like cellulase compositions
10/02/2003US20030186415 Mutant possessing uracil phosphoribosyl transferase activity
10/02/2003US20030186408 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030186407 Comprises membrane protein for use as antitumor/antiproliferative/antiinflammatory/anticarcinogenic agents
10/02/2003US20030186390 Detecting or determining transfer of nucleotide sequences via gene expression or reporter molecule expression analysis in transformed cells
10/02/2003US20030186383 Comprise nucleotide sequences coding growth factor polypeptide for diagnosing and treating autoimmune, cell proliferative, atherosclerotic, inflammatory and cancer disorders; tissue engineering; wound healing agents
10/02/2003US20030186381 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/02/2003US20030186374 Multimeric polypeptide plasmid for expression of complex heterologous proteins
10/02/2003US20030186370 Comprises nucleotide sequences coding nicotinic-acetylcholine receptor (5-ht3) for use in screening nematocides, insecticides and/or pesticides
10/02/2003US20030186369 Egg specific surface proteins
10/02/2003US20030186367 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030186366 For stimulating release of tumor necrosis factor and/or cellular differentiation of chondrocytes, endothelial cells or adipocytes by contacting blood with pro-polypeptide; cancer diagnosis and treatment
10/02/2003US20030186363 Method for cloning and expression of BsaI restriction endonuclease and BsaI methylase in E. coli
10/02/2003US20030186359 Genes encoding insect odorant receptors and uses thereof
10/02/2003US20030186358 Comprise nucleotide sequences coding membrane protein for use as antitumor, antiproliferative, anticarcinogenic or antiinflammatory agents
10/02/2003US20030186357 Vertebrate embryonic pattern-inducing proteins, and uses related thereto
10/02/2003US20030186355 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes
10/02/2003US20030186343 Immunoglobulin which binds low density lipoprotein receptor for diagnosis, prevention or treatment of viral infections; viricides
10/02/2003US20030186337 Novel death associated proteins, and THAP1 and PAR4 pathways in apoptosis control
10/02/2003US20030186335 Monoclonal antibody for use as diagnostic tool in the isolation of cells from the ependymal and subependymal layers of human brain
10/02/2003US20030186333 Comprises nervous system polypeptide for diagnosis, prognosis, treatment and evaluation of neurodegenerative disorders
10/02/2003US20030186324 Sensory neuron receptors
10/02/2003US20030186319 Comprises nucleotide sequences coding membrane protein for use as antiinflammatory/antitumor/anticarcinogenic/ antiproliferative agents
10/02/2003US20030186318 Comprises nucleotide sequences coding membrane protein for use as antiinflammatory/antitumor/anticarcinogenic/ antiproliferative agents
10/02/2003US20030186316 Method for identifying optimal binding ligands to a receptor
10/02/2003US20030186308 Prostacyclin-stimulating factor-2
10/02/2003US20030186306 Nucleotide sequences coding interleukins for treating tumors, bone, nervous system, neovascularization and autoimmune disorders
10/02/2003US20030186305 Novel proteins
10/02/2003US20030186290 Gene involved in CADASIL, method of diagnosis and therapeutic application
10/02/2003US20030186275 Using bacterial peptides to develop vaccine to protect against mycobacterium infections
10/02/2003US20030186270 Compositions and methods for reverse transcription of nucleic acid molecules
10/02/2003US20030186269 Ssa-56 kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
10/02/2003US20030186264 Comprises enzymatic polypeptide for diagnosis and treatment of genetic disorders; drug screening; immunoassay; high throughput assay
10/02/2003US20030186253 Fibroblast growth factor-13
10/02/2003US20030186249 Comprises nucleotide sequences coding a thymocyte cyclic AMP regulated phosphoprotein (TARPP) for treating, diagnosing, monitoring, prognosticating or preventing nervous system disorders
10/02/2003US20030186238 RNA detection assays
10/02/2003US20030186236 Diagnosis and prevention of infectibity of swine with porcine reproductive and respiratory syndrome virus; viricides; animal husbandry
10/02/2003US20030186232 Human and non-human primate homologues of Nkd protein, nucleic acid sequences encoding, and uses thereof
10/02/2003US20030186229 Emission ratiometric indicators of phosphorylation
10/02/2003US20030186219 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits
10/02/2003US20030186213 Storage solution containing photosensitizer for inactivation of biological contaminants
10/02/2003US20030185905 Plant extracts for the treatment of increased bone resorption
10/02/2003US20030185870 Oligopeptide binding agent including a first ligand that specifically binds a non-biological substrate and a second ligand that specifically binds a biological substrate.
10/02/2003US20030185849 React with convalescent phase antiserum from an E. canis-infected dog; useful in the development of vaccines and serodiagnostics
10/02/2003US20030185846 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030185842 Heat shock protein-based vaccines and immunotherapies
10/02/2003US20030185830 Compositions and methods for the therapy and diagnosis of prostate cancer
10/02/2003US20030185823 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient.
10/02/2003US20030185819 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation.
10/02/2003US20030185818 Humanized antibody against cd18
10/02/2003US20030185817 Method for separating cells using immunorosettes
10/02/2003US20030185815 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/02/2003US20030185810 Tumor radiosensitization using gene therapy
10/02/2003US20030185809 First population of mammalian cells transfected or transduced with a gene that is sought to be expressed, and a second population of mammalian cells that have not been transfected or transduced with the gene
10/02/2003US20030185808 Prostate cell lines
10/02/2003US20030185807 Administering a cell that expresses at least one factor of the T-box family, such as brachyury.
10/02/2003US20030185805 Use of stem cells derived from dermal skin
10/02/2003US20030185803 Autologous bone graft material
10/02/2003US20030185801 Packaging cell line capable of complementing recombinant adenoviruses based on serotypes from subgroup B, preferably adenovirus type 35.
10/02/2003US20030185800 Human interferon-epsilon: a type I interferon
10/02/2003US20030185790 Methods of ex-vivo expansion of hematopoeitic cells using multivariant IL-3 hematopoiesis chimera proteins
10/02/2003CA2480561A1 Method of proliferating human hepatocytes and method of obtaining human hepatocytes
10/02/2003CA2480559A1 Antibody recognizing proliferative human liver cells, proliferative human liver cells and functional human liver cells
10/02/2003CA2480099A1 Erbb3 based methods and compositions for treating neoplasms
10/02/2003CA2480059A1 Monoclonal antibody against interleukin-13 receptor alpha 1 (il-13r.alpha.1)
10/02/2003CA2479732A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003CA2479731A1 Novel compositions and methods in cancer associated with altered expression of tbx21
10/02/2003CA2479730A1 Novel compositions and methods in cancer
10/02/2003CA2479727A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
10/02/2003CA2479723A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
10/02/2003CA2479721A1 Novel compositions and methods in cancer associated with altered expression of prlr
10/02/2003CA2479719A1 Novel compositions and methods in cancer associated with altered expression of mcm3ap
10/02/2003CA2479587A1 Nucleic acid constructs and methods for producing altered seed oil compositions
10/02/2003CA2479582A1 Muscle cells and their use in cardiac repair
10/02/2003CA2479530A1 Hiv therapeutic
10/02/2003CA2479288A1 Process for producing cytotoxic lymphocyte
10/02/2003CA2479158A1 Recombinant expression vectors for functional nav1.9 sodium channels
10/02/2003CA2478839A1 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003CA2478220A1 Method for the detection of prion proteins
10/02/2003CA2478063A1 Lymphatic and blood endothelial cell genes
10/02/2003CA2477812A1 A non-selective cation channel in neural cells and methods for treating brain swelling
10/01/2003EP1348766A1 Method and kit for detecting membrane protein-protein interactions
10/01/2003EP1348764A1 A Method of Producing a Taxane-Type Diterpene and Method of Obtaining Cultured Cells which Produce the Taxane-Type Diterpene at a High Rate
10/01/2003EP1348758A1 Host cells having improved cell survival properties and methods to generate such cells
10/01/2003EP1348715A2 CD19xCD3 specific polypeptides and uses thereof
10/01/2003EP1348453A1 Autologous bone graft material
10/01/2003EP1348116A2 Focused acoustic ejection cell sorting system and method
10/01/2003EP1348033A2 Reagents and methods for identifying and modulating expression of genes regulated by retinoids
10/01/2003EP1348029A2 Materials and methods relating to protein aggregation in neurodegenerative disease
10/01/2003EP1348027A2 Gene disruption methodologies for drug target discovery
10/01/2003EP1348026A2 Fibrin binding moieties useful as imaging agents
10/01/2003EP1348022A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/01/2003EP1348019A1 System for the cell-specific and development-specific selection of differentiating embryonic stem cells, adult stem cells and embryonic germline cells
10/01/2003EP1347993A2 Superficial zone protein and methods of making and using same
10/01/2003EP1347992A2 Polymorphic bone morphogenetic protein 2
10/01/2003EP1347772A2 Educated nk t cells and their uses in the treatment of immune-related disorders
1 ... 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 ... 1827